Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
-
Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
-
Maxim Group Downgrades Onconova Therapeutics (ONTX) to Hold
-
Maxim Group Upgrades Onconova Therapeutics (ONTX) to Buy
-
Maxim Group Downgrades Onconova Therapeutics (ONTX) to Hold
-
UPDATE: Maxim Group Upgrades Onconova Therapeutics (ONTX) to Buy
-
Maxim Group Downgrades Onconova Therapeutics (ONTX) to Hold
-
Maxim Group Starts Onconova Therapeutics (ONTX) at Buy
-
Onconova Closes Oversubscribed Rights Offering with Gross Proceeds of $17.4 Million
-
Onconova Announces Expiration of Oversubscribed Rights Offering
-
Onconova Adjusts Pricing of Rights Offering
-
Onconova Announces Commencement of Subscription Period for Previously Announced Rights Offering
-
Onconova Reminds Shareholders That Rights Offering Ownership Day is Friday, July 1, 2016
-
Onconova Announces Price Range and Change of Key Dates for Rights Offering
-
Onconova Informs Stockholders of Key Dates Related to Announced Rights Offering
-
Onconova Files S-1 Registration Statement for Rights Offering to Shareholders
